VivoSeq
Other

Lung Transplant

0

Pipeline Programs↗

5

Active Trials↗

0

Companies Involved↗

Lung Transplant is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

56/100

Attrition Rate

29/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

14

clinical trials

Completed5 · 36%
Active, not recruiting3 · 21%
Terminated3 · 21%
Enrolling by invitation1 · 7%
Withdrawn1 · 7%
Recruiting1 · 7%

Clinical Trials

Trial Activity

14 trials

The Effect of the Reflux Band™ Upper Esophageal Sphincter (UES) Assist Device on Reflux for Lung Transplant Recipients
Recruiting·UUniversity of Florida·Preclinical·NCT03886961·20 enrolled
Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3)
Active, not recruiting·—·Phase 3·NCT04039347·262 enrolled
Advanced Immunoclinical Phenotyping of Rejection in Lung Transplant
Active, not recruiting·UUniversity of Virginia·Phase 2·NCT03697395·1,200 enrolled
Lung Transplant HCV, Pilot Study
Active, not recruiting·UUniversity Health Network, Toronto·Phase 1·NCT03112044·26 enrolled
RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant
Enrolling by invitation·NNorthwestern University·Phase 1·NCT05950724·20 enrolled
Envarsus XR in Lung Transplant
Completed·NNYU Langone Health·Phase 2·NCT04420195·41 enrolled
Preliminary Study of Dornase Alfa to Treat Chest Infections Post Lung Transplant.
Completed·—·Phase 2·NCT01952470·32 enrolled
Paravertebral Catheter for Lung Transplant
Completed·UUniversity of Minnesota·N/A·NCT02380417·33 enrolled
Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0
Completed·—·Phase 1·NCT03226431·6 enrolled
Lung Transplant Subjects Using 19F MRI
Completed·—·Phase 1·NCT02019251·6 enrolled
Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung Transplant
Terminated·MMassachusetts General Hospital·Phase 4·NCT03625687·19 enrolled
Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction
Terminated·GGladwin, Mark, MD·Phase 2·NCT01715883·3 enrolled
The Effect of Early Treatment of PC945 on Aspergillus Fumigatus Lung Infection in Lung Transplant Patients.
Terminated·PPulmocide Ltd·Phase 2·NCT03905447·2 enrolled
Perioperative Vitamin C Lung Transplant
Withdrawn·UUniversity of Wisconsin, Madison·Phase 2·NCT04505878

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)